Associate Director/Director, Immunology

What if… you could join an organization that creates, resources, and builds life sciences companies that invent breakthrough technologies to transform human health and sustainability?

Flagship Pioneering's venture creation engine has conceived and created companies such as Moderna Therapeutics (NASDAQ: MRNA), Sana Biotechnology (NASDAQ: SANA), Generate Biomedicines, and Tessera Therapeutics. Since its launch in 2000, Flagship has applied its unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $212 billion in aggregate value. To date, Flagship has deployed over $2.5 billion in capital toward the founding and growth of its pioneering companies alongside more than $19 billion of follow-on investments from other institutions. In 2021, Flagship Pioneering was ranked 12^th globally on Fortune’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies.

The Company:

Quotient Therapeutics, Inc. is a privately held, early-stage company developing a novel genomics platform and therapeutics for diseases with a large unmet need.

Position Summary:

We are seeking a dynamic and experienced Associate Director/Director, Immunology to lead our autoimmune projects in the early discovery stage. The ideal candidate will be a strategic leader with a strong background in immunology, autoimmune diseases, and drug discovery. This individual will play a key role in driving research and development efforts to advance novel therapies for autoimmune disorders and will report to our Senior Director of Translational Biology and Pharmacology.

Responsibilities:

• Lead and oversee Immunology-related activities for autoimmune projects in the early discovery phase
• Develop and implement innovative research strategies to identify and validate drug targets for autoimmune diseases
• Collaborate with cross-functional teams to design and execute preclinical studies, including in vitro and in vivo experiments
• Manage a team of scientists and research associates, providing mentorship, guidance, and support to ensure project success
• Stay current on the latest advancements in immunology and autoimmune research, and apply relevant knowledge to project development
• Drive the development of novel immunotherapies and therapeutic modalities for autoimmune disorders through innovative research and scientific approaches

Qualifications:

• Ph.D. in Immunology, Biochemistry, Molecular Biology, or a related field with at least 5 years of industry experience in immunology research, with a focus on autoimmune diseases
• Proven track record of leading early discovery projects in the pharmaceutical or biotechnology industry
• Strong expertise in immunological assays, cellular and molecular biology techniques, and drug target validation
• Excellent leadership and communication skills, with the ability to collaborate effectively with internal and external stakeholders
• Prior experience managing a team of multiple scientists at varying levels and guiding research projects from concept to preclinical development
• Strong publication record in immunology and autoimmune research, with a demonstrated impact in the field 

Location: Cambridge, MA 

About Flagship

Flagship Pioneering is a bioplatform innovation company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $90 billion in aggregate value. Many of the companies Flagship has founded have addressed humanity’s most urgent challenges: vaccinating billions of people against COVID-19, curing intractable diseases, improving human health, preempting illness, and feeding the world by improving the resiliency and sustainability of agriculture.  Flagship has been recognized twice on FORTUNE’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies, and has been twice named to Fast Company’s annual list of the World’s Most Innovative Companies. Learn more about Flagship at www.flagshippioneering.com.

Last updated on Aug 8, 2024